The Norwegian Minister of Health Bent Høie will see how medical equipment in a simple and efficient way can increase quality for a large number of medical procedures. ConceptoMed is moving front stage to initiate and elevate focus on quality during the billions of small procedures being executed worldwide.
Having consistently delivered significant business growth and sales achievement for leading medical device and pharmaceutical companies, such as Eli Lilly, Stryker, Abbott and Abbvie, Jan Arne Jakobsen is now moving back to Norway to apply his expertise as Chief Commercial Officer in ConceptoMed from 1st of June 2015.
The Board of Directors of ConceptoMed AS have the pleasure of announcing the successful completion of a private placement of equity in ConceptoMed AS. Gross proceeds from the private placement amounts to NOK 9.5 Million (€1.05 Million).
On Monday 19th of January 2015, Runar Bjørklund, shareholder in ConceptoMed AS and former CFO of Nycomed, was appointed new Chairman of the Board.
The Board of Directors of ConceptoMed AS have the pleasure of announcing the successful completion of a private placement of equity in ConceptoMed AS. The share issue was oversubscribed and provided the company with 12 new shareholders. Gross proceeds from the private placement amounted to NOK 11,550,000 (€1.42 Million)
The Intellectual Property Office in the United Kingdom has granted approval for a UK Patent for ConceptoShield™.
This grant is ConceptoMed’s second granted patent. More importantly, the patent is the “mother” patent for the second product line from ConceptoMed – the ConceptoShield™ – and will be applied to other product concepts in development.
Luer-Jack™ is a unique medical syringe, which significantly increases control of the syringe and needles during disconnections. The Intellectual Property Office in the United Kingdom has granted approval for a UK Patent for fluid transfer devices (Luer-Jack™). The patent is ConceptoMed’s first granted patent and will be applied to other products in development.